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To the Editor:
We studied the association of modest alcohol consumption and
steatohepatitis in a large sample of well-characterized study par-
ticipants with biopsy-proven non-alcoholic fatty liver disease
(NAFLD) from referral centers across the United States. Modest
alcohol consumption was associated with signiﬁcantly lower
odds of non-alcoholic steatohepatitis (NASH). Feng et al. raise
questions about diabetes and soft drink consumption as potential
confounders.
The ﬁrst question about diabetes speaks to one possible mech-
anism by which alcohol could lower the odds for NASH. Diabetes
has consistently been shown to be a major risk factor for steato-
hepatitis. In order to be considered a confounder, a factor must be
associated with both the exposure and outcome, but cannot be in
the causal pathway. Therefore, our main analysis did not include
the diagnosis of diabetes as a confounder because diabetes is
thought to be in the causal pathway. We did, however, perform
a series of sensitivity analyses to address such issues. Sensitivity
analysis #4 adjusted for the diagnosis of diabetes and showed
that the odds ratio between modest alcohol and NASH was atten-
uated from 0.52 (95% CI 0.36–0.76) to 0.58 (95% CI 0.41–0.84).
Thus as evidenced by this small attenuation, the effect of modest
alcohol on steatohepatitis may in part be manifested through
reduced prevalence of diabetes, but this is not likely to be the
major explanation for the lower odds of steatohepatitis.
While we adjusted for an extensive list of social, demographic
and lifestyle covariates, the possibility remains for any epidemi-
ology study that the exposure of interest is a surrogate marker of
other unmeasured factors. The second question posed by Feng
et al. was whether non-drinkers may consume greater amounts
of soft drinks, especially those containing fructose. Thus, soft
drink consumption could be one of the unmeasured factors,
because previous data has suggested an association between
fructose consumption and an increased risk for NAFLD [1,2] and
NASH. We performed a literature search, but were unable to ﬁnd
published studies comparing soft drink consumption between
non-drinkers and modest drinkers. Thus it is unclear whether
the amount of soft drink consumption was different between
our two groups. However, in our main analysis we did adjust
for total calories per day and percent calories from carbohydrates.
Neither of these adjustments attenuated the association between
modest alcohol and lower odds of having NASH.
Beyond issues of mechanism and statistical analyses, the
question of whether or not to permit adult patients with NAFLDJournal of Hepatology 20to drink alcohol in modest amounts remains controversial. As
opposed to being harmful, many studies now support the belief
that modest alcohol consumption in adults with NAFLD could
be beneﬁcial. However, to date no studies can deﬁnitively
support nor refute this contention. Therefore, hepatologists are
not uniﬁed on this issue and thus fall into one of three camps:
(1) those that continue to recommend strict avoidance; (2) those
that counsel their patients that heavy drinking is bad, but that
there is not enough evidence to know whether modest alcohol
is good or bad, and (3) those that have taken to proactively
recommending one alcoholic beverage a few times per week. In
order to move past the controversy and know how to best coun-
sel our patients will require collaborations to further build the
evidence than can support a clinical consensus.
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